Prometheus Biosciences Inc (RXDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 61,147 | 32,626 | 24,340 | 23,469 | 38,718 |
| Marketable Securities | 104,231 | 71,361 | 83,637 | 98,944 | 111,968 |
| TOTAL | $169,336 | $107,962 | $111,850 | $129,285 | $157,306 |
| Non-Current Assets | |||||
| PPE Net | 4,675 | 5,495 | 6,270 | 30,087 | 23,726 |
| Investments And Advances | 4,000 | 4,000 | 24,983 | 30,070 | 23,963 |
| Other Non-Current Assets | 1,520 | 1,696 | 1,811 | 343 | 343 |
| TOTAL | $10,195 | $11,191 | $33,064 | $60,500 | $48,032 |
| Total Assets | $179,531 | $119,153 | $144,914 | $189,785 | $205,338 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 17,420 | 19,479 | 13,510 | 2,128 | 1,708 |
| Accrued Expenses | 2,057 | 1,542 | 4,007 | 11,641 | 12,892 |
| Other current liabilities | 3,709 | N/A | N/A | N/A | N/A |
| TOTAL | $23,186 | $21,021 | $17,517 | $13,957 | $14,785 |
| Non-Current Liabilities | |||||
| Long Term Debt | 29,838 | 29,679 | 29,517 | 29,352 | 29,183 |
| Other Non-Current Liabilities | 11,628 | 10,472 | 3,110 | 25,687 | 19,181 |
| TOTAL | $41,466 | $40,151 | $32,627 | $55,039 | $48,434 |
| Total Liabilities | $64,652 | $61,172 | $50,144 | $68,996 | $63,219 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 56,254 | 41,837 | 41,700 | 41,653 | 41,652 |
| Common Shares | 6 | 4 | 4 | 4 | 4 |
| Retained earnings | -320,097 | -291,819 | -251,660 | -223,451 | -200,163 |
| Other shareholders' equity | -91 | -99 | -123 | -15 | 63 |
| TOTAL | $114,879 | $57,981 | $94,770 | $120,789 | $142,119 |
| Total Liabilities And Equity | $179,531 | $119,153 | $144,914 | $189,785 | $205,338 |